Next Article in Journal
A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson’s Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response
Previous Article in Journal
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14®) Administered at 6–10–14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial
 
 
Article

Article Versions Notes

Vaccines 2026, 14(6), 465; https://doi.org/10.3390/vaccines14060465
Action Date Notes Link
article supplementary file uploaded. 22 May 2026 17:10 CEST - https://www.mdpi.com/2076-393X/14/6/465#supplementary
article pdf uploaded. 22 May 2026 17:10 CEST Version of Record https://www.mdpi.com/2076-393X/14/6/465/pdf
Back to TopTop